The global market for Syringes was valued at US$16.3 Billion in 2024 and is projected to reach US$24.2 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Syringes market.
Technological advancements and product innovation are another major trend shaping the market's trajectory. The development of safety syringes with retractable needles to minimize the risk of accidental needlesticks and the spread of infections is gaining traction. Pre-filled syringes have also emerged as a preferred choice due to their convenience, precise dosing, and reduced preparation time, especially for administering vaccines and biologics. The growth of biologic drugs, which require injectable delivery, supports market demand. Advances in drug formulations are enabling subcutaneous delivery, making at-home treatment feasible for chronic diseases such as autoimmune disorders and certain cancers. This has transformed how pharmaceutical companies approach treatment delivery, encouraging them to decide on the best delivery methods earlier in development. As a result, development processes are streamlined, reducing both costs and testing time. Additionally, the shift toward more eco-friendly, disposable syringes is gaining importance, as hospitals and clinics seek to minimize the environmental impact of medical waste.
Government initiatives and regulations promoting the safe use and disposal of syringes have further influenced market growth. Many regions have implemented policies that mandate the use of safety-engineered syringes to reduce the risk of healthcare-associated infections. Moreover, the global push for mass immunization, particularly in developing countries with large populations, has spurred international organizations to increase funding for syringe procurement and distribution. Sustainability remains a significant concern as single-use auto-injectors and PFS contribute to plastic waste, unlike recyclable glass vials. Nevertheless, these devices have proven advantageous by improving dosing accuracy, reducing medication wastage, and potentially lowering pharmaceutical waste. Their reusable variants offer a solution, potentially mitigating environmental impacts while maintaining user-friendly design. Additionally, fewer administration errors mean better resource conservation.
Segments: Product Type (Prefilled Syringes, Disposable Safety Syringes, Disposable Conventional Syringes, Sterilizable Syringes).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Syringes Market - Key Trends and Drivers Summarized
The global syringes market is witnessing significant growth, driven by the increasing prevalence of chronic diseases and the rising need for medical and diagnostic procedures. As conditions such as diabetes, cancer, and autoimmune diseases become more common, the demand for syringes is on rise due to the frequent need for insulin administration, chemotherapy, and other injectable treatments. The healthcare industry's response to infectious diseases such as COVID-19 has also accelerated demand, with mass vaccination campaigns necessitating millions of syringes globally. This uptick in chronic and infectious diseases is a primary factor fueling the expansion of the syringe market.Technological advancements and product innovation are another major trend shaping the market's trajectory. The development of safety syringes with retractable needles to minimize the risk of accidental needlesticks and the spread of infections is gaining traction. Pre-filled syringes have also emerged as a preferred choice due to their convenience, precise dosing, and reduced preparation time, especially for administering vaccines and biologics. The growth of biologic drugs, which require injectable delivery, supports market demand. Advances in drug formulations are enabling subcutaneous delivery, making at-home treatment feasible for chronic diseases such as autoimmune disorders and certain cancers. This has transformed how pharmaceutical companies approach treatment delivery, encouraging them to decide on the best delivery methods earlier in development. As a result, development processes are streamlined, reducing both costs and testing time. Additionally, the shift toward more eco-friendly, disposable syringes is gaining importance, as hospitals and clinics seek to minimize the environmental impact of medical waste.
Government initiatives and regulations promoting the safe use and disposal of syringes have further influenced market growth. Many regions have implemented policies that mandate the use of safety-engineered syringes to reduce the risk of healthcare-associated infections. Moreover, the global push for mass immunization, particularly in developing countries with large populations, has spurred international organizations to increase funding for syringe procurement and distribution. Sustainability remains a significant concern as single-use auto-injectors and PFS contribute to plastic waste, unlike recyclable glass vials. Nevertheless, these devices have proven advantageous by improving dosing accuracy, reducing medication wastage, and potentially lowering pharmaceutical waste. Their reusable variants offer a solution, potentially mitigating environmental impacts while maintaining user-friendly design. Additionally, fewer administration errors mean better resource conservation.
Report Scope
The report analyzes the Syringes market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.Segments: Product Type (Prefilled Syringes, Disposable Safety Syringes, Disposable Conventional Syringes, Sterilizable Syringes).
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Prefilled Syringes segment, which is expected to reach US$10.6 Billion by 2030 with a CAGR of a 8.3%. The Disposable Safety Syringes segment is also set to grow at 6.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $4.3 Billion in 2024, and China, forecasted to grow at an impressive 11.3% CAGR to reach $5.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Syringes Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Syringes Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Syringes Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, Kawamoto Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 101 companies featured in this Syringes market report include:
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health
- Kawamoto Corporation
- Medline Industries Inc.
- Merit Medical Systems
- Nipro Medical Corporation
- Retractable Technologies
- Smiths Medical
- Terumo Corporation
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Cardinal Health
- Kawamoto Corporation
- Medline Industries Inc.
- Merit Medical Systems
- Nipro Medical Corporation
- Retractable Technologies
- Smiths Medical
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 303 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 16.3 Billion |
| Forecasted Market Value ( USD | $ 24.2 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
